CYCLOPHARM LIMITED ORDINARY (CYC) Short Interest
CYCLOPHARM LIMITED ORDINARY (ASX:CYC) had 0.00% of shares reported as short positions as of 26 June 2026, representing 4,406 shares. CYCLOPHARM LIMITED ORDINARY operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
CYC
Cyclopharm
Health Care Equipment & Services
Cyclopharm is a global radiopharmaceutical company focused on lung imaging solutions. Their flagship product, Technegas, is used for pulmonary embolism diagnosis and other lung conditions. The company aims to advance nuclear pulmonology imaging through innovation and a commitment to superior patient care.
Shorted
short percentage0.00%
reported shorts4.4K
shares on issue126.066M